ORAL DRUGS FOR PATHOGENETIC TREATMENT OF MULTIPLE SCLEROSIS

This article presents a review of the efficacy and safety of three oral drugs for multiple sclerosis, which are registered in the Russian Federation: teriflunomide, dimethylfumarate, fingolimod.

Bibliographic Details
Main Authors: E. V. Popova, A. N. Boyko, E. I. Gusev
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-07-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1912